Avsnitt
-
In this podcast, Michael Miller covers all the hot topics surrounding Rapid and Alternative Microbiology Methods in the pharmaceutical industry.
Of course, we also take a deep dive into the brand-new PDA Technical Report 33, released in July 2026.
Among the topics discussed:
How do you build a business case and calculate the ROI of an RMM?Should we say RMM, ARMM, or Modern Methods?Why have so few RMMs been validated so far?Why is now the right time to adopt RMMs?How do you choose the most appropriate RMM for your laboratory?And don't miss the Selection of the 4 Best Rapid Microbiology Methods and their challengers.
Enjoy the podcast!
Content :
00:27 Introduction to Rapid Microbiology Methods03:06 Early Experiences in Pharmaceutical Microbiology
05:41 Regulatory Changes and Their Impact
08:36 Technical Report 33 Overview
11:52 Collaboration with Regulatory Agencies
14:45 The Future of Rapid Microbiology Methods
17:41 Understanding Terminology in Microbiology Methods
20:41 Supplier Collaboration and Industry Expectations
37:36 Validation Protocols and Statistical Analysis
42:04 Success Stories in Pharmaceutical Manufacturing
47:46 The Importance of Rapid Methods in ATMPs
51:25 Challenges in User Requirement Specifications
53:43 Trusting Supplier Validation
56:38 The Future of Rapid Micro Methods
01:00:42 Conferences and Resources for Rapid Microbiology
01:10:25 Conclusion and Future Outlook
-
Saknas det avsnitt?
